Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06361173 · ClinicalTrials.gov registry record
Spanish BMT4me Usability & Acceptability
A clinical trial, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- 30
- Enrollment target
NCT06361173: Completed study, sponsored by Nationwide Children's Hospital.
NCT06361173 is a clinical trial that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06361173 has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The objective of this project is to trans-create, conduct user testing of a previously developed and piloted mHealth app, and user acceptability with parents of children in the acute phase post-allogeneic hematopoietic stem cell transplant (HSCT). Nationwide Children's Hospital (NCH) will be the primary data collection site and Columbia University Irving Medical Center will be a secondary site.
Primary Outcome
Data collected using the System Usability Scale (SUS) will provide insight to the usability of the Spanish BMT4Me app in its current form. he SUS is a 10-item questionnaire routinely used to evaluate the functionality and acceptability of mHealth apps. The SUS is scored on a scale, giving a score from from 0 to 100 where 100 is considered the highest rating of usability. A score of \> 68 is considered above average.
Interventions
- OTHER BMT4me
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-10-09 |
| Est. Completion | 2025-09-24 |
What the finished NCT06361173 record still lists
NCT06361173 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which BMT4me is the first listed.
NCT06361173 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06361173 about?
NCT06361173 is a clinical study titled "Spanish BMT4me Usability & Acceptability". The objective of this project is to trans-create, conduct user testing of a previously developed and piloted mHealth app, and user acceptability with parents of children in the acute phase post-allogeneic hematopoietic stem cell transplant (HSCT). Nationwide Children's Hospital (NCH) will be the pri...
What is the current status of trial NCT06361173?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2024-10-09. Estimated completion is 2025-09-24.
What interventions are being tested in trial NCT06361173?
The interventions under investigation include: BMT4me (OTHER).
Who is sponsoring clinical trial NCT06361173?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI